Search

Your search keyword '"Jonas, Jeffrey"' showing total 246 results

Search Constraints

Start Over You searched for: Author "Jonas, Jeffrey" Remove constraint Author: "Jonas, Jeffrey" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
246 results on '"Jonas, Jeffrey"'

Search Results

4. Hurricanes and Climate: The U.S. CLIVAR Working Group on Hurricanes

5. Characteristics of tropical cyclones in high‐resolution models in the present climate

15. CORRECTION: HURRICANES AND CLIMATE: THE U.S. CLIVAR WORKING GROUP ON HURRICANES

16. Symmetric Equations on the Surface of a Sphere as Used by Model GISS:IB

20. ENSO Modulation of the QBO Periods in GISS E2.2 Models.

21. Climate responses to SATIRE and SIM-based spectral solar forcing in a 3D atmosphere-ocean coupled GCM

23. Patient-reported health-related quality of life from a randomized, placebo-controlled phase 2 trial of zuranolone in adults with major depressive disorder

24. A Double-Blind, Randomized, Placebo-Controlled Trial of Escitalopram in the Treatment of Pediatric Depression

26. Tropical Cyclones in the GISS ModelE2

29. Effect of Zuranolone vs Placebo in Postpartum Depression

34. The QBO in Two GISS Global Climate Models: 1. Generation of the QBO

35. The Role of Long-Lived Greenhouse Gases as Principal LW Control Knob that Governs the Global Surface Temperature for Past and Future Climate Change

36. GISS Model E2.2: A Climate Model Optimized for the Middle Atmosphere—2. Validation of Large‐Scale Transport and Evaluation of Climate Response

37. How Well Do Global Climate Models Simulate the Variability of Atlantic Tropical Cyclones Associated with ENSO?

38. A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy of SAGE-217 in the Treatment of Adult Patients With Major Depressive Disorder

39. 934: Phase 3, randomized, placebo-controlled trial of SAGE-217 in postpartum depression: Association between HAM-D and PHQ-9

40. A phase 1 double‐blind, placebo‐controlled study of zuranolone (SAGE‐217) in a phase advance model of insomnia in healthy adults.

43. Trial of SAGE-217 in Patients with Major Depressive Disorder

44. T111. Patient-Reported Health-Related Quality of Life Correlates Inversely With Depressive Symptoms in a Pivotal Trial of SAGE-217 in Major Depressive Disorder

46. Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials

48. O46. SAGE-217 a First in Class GABAA Receptor Positive Allosteric Modulator in Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Phase 2 Placebo-Controlled Trial

49. Triazolam

50. Triazolam

Catalog

Books, media, physical & digital resources